Researchers at Stanford have developed Evo 2, a DNA generative AI tool.The tool is trained on a dataset of over 100,000 organisms and can identify mutations that contribute to diseases.Evo 2 can generate gene sequences and cross-reference them with existing sequences, aiding in predicting their real-life impact.The technology raises concerns about potential negative consequences and the risk of creating more dangerous diseases.